BioVie
BIVI
47 hedge funds and large institutions have $13M invested in BioVie in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 8 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 6
113% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 8
37% more capital invested
Capital invested by funds: $9.5M → $13M (+$3.49M)
21% more funds holding
Funds holding: 39 → 47 (+8)
0.01% more ownership
Funds ownership: 0.04% → 0.05% (+0.01%)
1% less call options, than puts
Call options by funds: $558K | Put options by funds: $564K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.31M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$1.28M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$840K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$729K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$418K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$2.31M |
| 2 |
Millennium Management
New York
|
-$608K |
| 3 |
6CM
683 Capital Management
New York
|
-$125K |
| 4 |
Man Group
London,
United Kingdom
|
-$121K |
| 5 |
FIA
FNY Investment Advisers
New York
|
-$110K |
BIVI Hedge Fund Activity: Q1 2023 in Review
47 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q1 2023, worth a combined $13M — up 37% from $9.5M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new BIVI positions and 8 closed out — a net gain of 9 holders — while 15 added to existing stakes and 6 trimmed.
The largest buyer was Ikarian Capital, opening a new position worth an estimated $2.31M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $2.31M sold.
- 47 institutional investors held BioVie (BIVI) as of Q1 2023, up from 39 in Q4 2022.
- Funds reported $13M of BioVie stock for Q1 2023, up 37% quarter-over-quarter.
- 17 funds opened new BioVie positions in Q1 2023 and 8 closed out, a net change of +9 holders.
- The largest BioVie buyer in Q1 2023 was Ikarian Capital, an estimated $2.31M added.
- The largest BioVie seller in Q1 2023 was Renaissance Technologies, an estimated $2.31M sold.
Based on aggregated 13F filings for Q1 2023.